Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Centocor Incorporated

Centocor, Inc. is a biopharmaceutical company that creates, acquires and markets therapies that yield long-term benefits forpatients and the healthcare community. Its products, developed through monoclonal antibody and other technologies, help physicians deliver innovative treatments to improve human health and restore patients' quality of life.


Contact Details:
200 Great Valley Parkway
Malvern
PA
19355-1307
United States of America
Tel:610 651 6000
Fax:610 651 6100
Email:
WWW:

www.centocor.com/




Loading...

Recent Publications by Centocor Incorporated:

Discovery and development of biopharmaceuticals: current issues.
The establishment of recombinant DNA technologies in the past several...
10th November, 2009
Biologics Research, Centocor R&D, Inc., Mailstop RA-2-4, 145 King of Curr Opin Biotechnol. 2009 Nov 5.
DOI Direct Link
Optimization of Fc-mediated effector functions of monoclonal antibodies.
The engineering of therapeutic and clinical candidate monoclonal...
10th November, 2009
Antibody Drug Discovery, Centocor R&D, Inc., Mailstop RA-2-4, 145 King of Curr Opin Biotechnol. 2009 Nov 4.
DOI Direct Link
Optimizing nucleotide sequence ensembles for combinatorial protein libraries using a genetic algorithm.
Protein libraries are essential to the field of protein engineering....
6th November, 2009
Department of Computer and Information Sciences, University of Delaware, Nucleic Acids Res. 2009 Nov 4.
DOI Direct Link
Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology.
Fc fusion proteins are molecules in which the immunoglobulin Fc is fused...
6th November, 2009
Discovery Research, Centocor R&D Inc., 145 King of Prussia Road, Radnor, Curr Opin Biotechnol. 2009 Nov 2.
DOI Direct Link
Toll-like receptor 3 is involved in airway epithelial cell response to nontypeable Haemophilus influenzae.
Nontypeable Haemophilus influenzae (NTHi) is the etiological agent most...
3rd November, 2009
Department of Immunology, Centocor R&D Inc., Radnor, PA, United States. Cell Immunol. 2009 Oct 1.
DOI Direct Link

View more Centocor Incorporated research publications.

BioNews Results for Centocor Incorporated:

Solar project unveiled
PhillyBurbs.com:  Nov 13 2009 6:51PM Matching: centocor
Stelara, first IL inhibitor, expected to change dermatologists prescribing habits and alter patient flow mo
News-Medical.Net:  Nov 12 2009 3:52PM Matching: centocor
Morphotek Signs a Pact with Centocor for a Therapeutic Monoclonal Antibody
BioPharm International:  Nov 11 2009 6:47PM Matching: centocor
Stelara is Expected to Substantially Alter Patient Flow to TNF-Alpha Inhibitors Prescribed for Psoriasis Over
Pharma Live:  Nov 11 2009 10:33PM Matching: centocor
Decision Resources: Biosimilars may cause biotech companies to lose more than $9 billion
Drug Store News:  Nov 11 2009 9:10PM Matching: centocor
Promote your company here: BioNewsCast - Press Release Distribution

View more Centocor Incorporated news.

Centocor Incorporated Clinical Trials:

A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

Centocor Incorporated Patents:

US Patent No.Title
7160542 Method of treating psoriasis using human anti-TNF antibodies and fragments
7226593 Methods of treating cachexia with chimeric anti-TNF antibodies
7227003 Anti-TNF antibody fragments
7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
7247711 IL-23p40 specific antibody

View more Centocor Incorporated patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 52 individuals from Centocor Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1522 times since April 2007, the link to the organisation's website has been followed 249 times

Recent Search Terms used to find this page: centocor november 2009 | abbott centocor november 2009 | Receptor-Fc fusion therapeutics traps and MIMETIBODY technology. | centocor incorporated | Sarcoidosis Centocor | centocor malvern benefits website | centocor and il-13 | centocor research and development malvern us map | centocor pharmacology departemnt | clinical pharmacology centocor | .

Search for more companies in Malvern

Search for more companies in PA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Centocor Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.